Literature DB >> 23571590

New approaches to molecular diagnosis.

Bruce R Korf1, Heidi L Rehm.   

Abstract

Advances in understanding the molecular basis of rare and common disorders, as well as in the technology of DNA analysis, are rapidly changing the landscape of molecular genetic and genomic testing. High-resolution molecular cytogenetic analysis can now detect deletions or duplications of DNA of a few hundred thousand nucleotides, well below the resolution of the light microscope. Diagnostic testing for "single-gene" disorders can be done by targeted analysis for specific mutations, by sequencing a specific gene to scan for mutations, or by analyzing multiple genes in which mutation may lead to a similar phenotype. The advent of massively parallel next-generation sequencing facilitates the analysis of multiple genes and now is being used to sequence the coding regions of the genome (the exome) for clinical testing. Exome sequencing requires bioinformatic analysis of the thousands of variants that are identified to find one that is contributing to the pathology; there is also a possibility of incidental identification of other medically significant variants, which may complicate genetic counseling. DNA testing can also be used to identify variants that influence drug metabolism or interaction of a drug with its cellular target, allowing customization of choice of drug and dosage. Exome and genome sequencing are being applied to identify specific gene changes in cancer cells to guide therapy, to identify inherited cancer risk, and to estimate prognosis. Genomic testing may be used to identify risk factors for common disorders, although the clinical utility of such testing is unclear. Genetic and genomic tests may raise new ethical, legal, and social issues, some of which may be addressed by existing genetic nondiscrimination legislation, but which also must be addressed in the course of genetic counseling. The purpose of this article is to assist physicians in recognizing where new approaches to genetic and genomic testing may be applied clinically and in being aware of the principles of interpretation of test results.

Entities:  

Mesh:

Year:  2013        PMID: 23571590     DOI: 10.1001/jama.2013.3239

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  51 in total

1.  Solute Carrier Family 26 Member a2 (slc26a2) Regulates Otic Development and Hair Cell Survival in Zebrafish.

Authors:  Fei Liu; Wenjun Xia; Jiongjiong Hu; Yingzhi Wang; Fan Yang; Shaoyang Sun; Jin Zhang; Nan Jiang; Huijun Wang; Weidong Tian; Xu Wang; Duan Ma
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

2.  National Institutes of Health Center for Regenerative Medicine: putting science into practice.

Authors:  Mahendra Rao
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

3.  A genetic counselor's guide to using next-generation sequencing in clinical practice.

Authors:  Flavia M Facio; Kristy Lee; Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2013-10-24       Impact factor: 2.537

Review 4.  Managing large-scale genomic datasets and translation into clinical practice.

Authors:  T Lecroq; L F Soualmia
Journal:  Yearb Med Inform       Date:  2014-08-15

5.  Introducing a New Competency Into Nursing Practice.

Authors:  Kathleen A Calzone; Jean Jenkins; Stacey Culp; Sarah Caskey; Laurie Badzek
Journal:  J Nurs Regul       Date:  2014-04

6.  Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology.

Authors:  Madhuri Hegde; Sherri Bale; Pinar Bayrak-Toydemir; Jane Gibson; Linda Jo Bone Jeng; Loren Joseph; Jordan Laser; Ira M Lubin; Christine E Miller; Lainie F Ross; Paul G Rothberg; Alice K Tanner; Patrik Vitazka; Rong Mao
Journal:  J Mol Diagn       Date:  2015-02-12       Impact factor: 5.568

Review 7.  Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.

Authors:  Ignatia B van den Veyver; Christine M Eng
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

Review 8.  Genomics, personalized medicine, and pediatrics.

Authors:  William Gregory Feero; Alan E Guttmacher
Journal:  Acad Pediatr       Date:  2014 Jan-Feb       Impact factor: 3.107

9.  Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records.

Authors:  Sara L Van Driest; Quinn S Wells; Sarah Stallings; William S Bush; Adam Gordon; Deborah A Nickerson; Jerry H Kim; David R Crosslin; Gail P Jarvik; David S Carrell; James D Ralston; Eric B Larson; Suzette J Bielinski; Janet E Olson; Zi Ye; Iftikhar J Kullo; Noura S Abul-Husn; Stuart A Scott; Erwin Bottinger; Berta Almoguera; John Connolly; Rosetta Chiavacci; Hakon Hakonarson; Laura J Rasmussen-Torvik; Vivian Pan; Stephen D Persell; Maureen Smith; Rex L Chisholm; Terrie E Kitchner; Max M He; Murray H Brilliant; John R Wallace; Kimberly F Doheny; M Benjamin Shoemaker; Rongling Li; Teri A Manolio; Thomas E Callis; Daniela Macaya; Marc S Williams; David Carey; Jamie D Kapplinger; Michael J Ackerman; Marylyn D Ritchie; Joshua C Denny; Dan M Roden
Journal:  JAMA       Date:  2016-01-05       Impact factor: 56.272

10.  Diagnosis of D-Bifunctional Protein Deficiency through Whole-Genome Sequencing: Implications for Cost-Effective Care.

Authors:  Alina Khromykh; Benjamin D Solomon; Dale L Bodian; Eyby L Leon; Ramaswamy K Iyer; Robin L Baker; David P Ascher; Rajiv Baveja; Joseph G Vockley; John E Niederhuber
Journal:  Mol Syndromol       Date:  2015-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.